0:00
23:05
Dr. Centor discusses the use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.
More episodes from "Annals On Call Podcast"
Don't miss an episode of “Annals On Call Podcast” and subscribe to it in the GetPodcast app.